Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain

Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is an infectious virus that was first reported in 2012. The MERS-CoV genome encodes four major structural proteins, among which the spike (S) protein has a key role in viral infection and pathogenesis. The receptor-binding domain (RBD) o...

Full description

Bibliographic Details
Main Authors: Yusen Zhou, Yang Yang, Jingwei Huang, Shibo Jiang, Lanying Du
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Viruses
Subjects:
Coronavirus
MERS-CoV
spike protein
receptor-binding domain
vaccines
therapeutics
Online Access:http://www.mdpi.com/1999-4915/11/1/60

Similar Items

Similar Items